Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer

Cancer Epidemiology

Volumn 34, Issue 3, 2010, Pages 291-297

  Kato, Ikuko ^a   Land, Susan ^a   Majumdar, Adhip P ^a,b   Barnholtz Sloan, Jill ^c   Severson, Richard K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Case control study; Colorectal cancer; Lipid absorption; Single nucleotide polymorphism (SNP)

Indexed keywords

ALANINE; APOENZYME; FATTY ACID BINDING PROTEIN 2; LIPID; THREONINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; COLORECTAL CANCER; CONTROLLED STUDY; EXON; FAT INTAKE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; IN VIVO STUDY; LIPID ABSORPTION; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; COLORECTAL NEOPLASMS; DISEASE SUSCEPTIBILITY; FATTY ACID-BINDING PROTEINS; FEMALE; GENE FREQUENCY; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77952293210     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.02.010     Document Type: Article

References (63)

1. WCRF/AICR. Colon and rectum. Food, nutrition, physical activity and the prevention of cancer: global perspective (2007), AICR, Washington, DC p. 280-8
2. Alexander D.D., Cushing C.A., Lowe K.A., Sceurman B., and Roberts M.A. Meta-analysis of animal fat or animal protein intake and colorectal cancer. Am J Clin Nutr 89 (2009) 1402-1419
3. Beresford S.A., Johnson K.C., Ritenbaugh C., Lasser N.L., Snetselaar L.G., Black H.R., et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295 (2006) 643-654
4. Reddy B.S. Dietary fat, calories, and fiber in colon cancer. Prev Med 22 (1993) 738-749
5. Tang Z.C., Shivapurkar N., Frost A., and Alabaster O. The effect of dietary fat on the promotion of mammary and colon cancer in a dual-organ rat carcinogenesis model. Nutr Cancer 25 (1996) 151-159
6. Babbs C.F. Free radicals and the etiology of colon cancer. Free Rad Bio Med 8 (1990) 191-200
7. Stone W.L., and Papas A.M. Tocopherols and the etiology of colon cancer. JNCI 89 (1997) 1006-1014
8. Erhardt J.G., Lim S.S., Bode J.C., and Bode C. A diet rich in fat and poor in dietary fiber increases the in vitro formation of reactive oxygen species in human feces. J Nutr 127 (1997) 706-709
9. Law M.R., and Thompson S.G. Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control 2 (1991) 253-261
10. Demers R.Y., Neale A.V., Demers P., Deighton K., Scott R.O., Dupuis M.H., et al. Serum cholesterol and colorectal polyps. J Clin Epidemiol 41 (1988) 9-13
11. Rumi Jr. G., Szabo I., Vincze A., Matus Z., Toht G., Rumi G., et al. Decrease in serum levels of vitamin A and zeaxanthin in patients with colorectal polyps. Eur Gastroenterol Hepatol 11 (1999) 305-308
12. Nomura A.M., Stermmermann G.N., and Chyou P.-H. Prospective studies of serum cholesterol levels and large-bowel cancer. JNCI 83 (1991) 1402-1407
13. Eichholzer M., Stähelin B., Gutzwiller F., Lüdin E., and Bernasconi F. Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study. Am J Clin Nutr 71 (2000) 569-574
14. Kreger B.E., Anderson K.M., Schayzkin A., and Splansky G.L. Serum cholesterol level, body mass index, and the risk of colon cancer. Cancer 70 (1992) 1038-1043
15. Schuit A.J., van Dijk C.E.M.J., Dekker J.M., Schouten E.G., and Kok F.J. Inverse association between serum total cholesterol and cancer mortality in Dutch Civil servants. Am J Epidemiol 137 (1993) 966-976
16. Gaard M., Tretli S., and Urdal P. A prospective study of 62,173 Norwegian men and women. Scand J Gastroenterol 32 (1997) 162-168
17. Baier L.J., Sacchettuni J.C., Knowler W.C., Eads J., Paolisso G., Tataranni P.A., et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation and insulin resistance. J Clin Invest 95 (1995) 1281-1287
18. Brouwer D.A.J., van Doormaal J.J., and Muskiet F.A.J. Clinical chemistry of common apolipoprotein E isoforms. J Chromatogr B 678 (1996) 23-41
19. Baier L.J., Bogardus C., and Sacchettini J.C. A polymorphism in the human intestinal fatty avid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271 (1996) 10892-10896
20. Georgopoulos A., Aras I., and Tsai M.Y. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of lasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 85 (2000) 3155-3160
21. Kesäniemi Y.A., Ehnholm C., and Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80 (1987) 578-581
22. Miettinen T.A., Gylling H., Vanhanen H., and Ollus A. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thomb 12 (1992) 1044-1052
23. Gylling H., Aalto-Setälä K., Kontula K., and Miettinen T.A. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia. Arterioscler Thromb 11 (1991) 1368-1375
24. Hegele R.A., Wolever T.M.S., Story J.A., Connelly P.W., and Jenkins D.J.A. Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur J Clin Invest 27 (1997) 857-862
25. Narisawa T., Magadia N.E., Weisburger J.H., and Wynder E.L. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation N-methyl-N′-nitro-N-nitrosoguanidine in rats. JNCI 53 (1974) 1093-1097
26. Block G., Woods M., Potosky A., and Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43 (1990) 1327-1335
27. Block G., Thompson F.E., Hartman A.M., Larkin F.A., and Guire K.E. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 92 (1992) 686-693
28. Willett W., and Stampfer M.J. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124 (1986) 17-27
29. Breslow NE, Day NE. Statistical methods in cancer research, vol. I: the analysis of case-control studies. IARC Scientific Publications No. 32. Lyon: IARC; 1980.
30. Chlebowski R.T., Wactawski-Wende J., Ritenbaugh C., Hubbell F.A., Ascensao J., Rodabough R.J., et al. Women's Health Initiative Investigators. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350 (2004) 991-1004
31. Huxley R.R., Ansary-Moghaddam A., Clifton P., Czernichow S., Parr C.L., and Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125 (2009) 171-180
32. Kato I., Nomura A., Stemmermann G.N., and Chyou P.-H. Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors. Dig Dis Sci 37 (1992) 784-790
33. Hegele R.A., Connelly P.W., Hanley A.J.G., Sun F., Harris S.B., and Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 17 (1997) 1060-1066
34. Pihlajamäki J., Rissanen J., Heikkinen S., Karjalaunen L., and Laakso M. A codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 17 (1997) 1039-1044
35. Vidgren H.M., Sipiläinen H., Heikkinen S., Laakso M., and Uusitupa M.I. Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Eur J Clin Invest 27 (1997) 405-408
36. Ågren J.J., Valve R., Vidgren H., Laakso M., and Uusitupa M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 18 (1998) 1606-1610
37. Ågren J.J., Vidgren H., Valve R., Laakso M., and Uusitupa M. Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr 73 (2001) 31-35
38. Kesäniemi Y.A. Genetics and cholesterol metabolism. Curr Opin Lipidol 7 (1996) 124-131
39. Gylling H., Kontula K., and Miettinen T.A. Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apoprotein B Xba I and LDL receptor Pvu II genotypes. Arterioscler Thromb Vasc Biol 15 (1995) 208-213
40. Gylling H., Kontula K., Koivisto U.-M., Miettinen H.E., and Miettinen T.A. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Arterioscler Thromb Vasc Biol 17 (1997) 38-44
41. Lopez-Miranda J., Ordovas J.M., Mata P., Lichtenstein A.H., Clevidence B., Judd J.T., et al. Effect of apolipoprotein E phenotype in diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 35 (1994) 1965-1975
42. Weggemans R.M., Zock P.L., Ordovas J.M., Perdp-Botet J., and Katan M.B. Apoprotein E genotype and the response of serum cholesterol to dietary fat, cholesterol and cafestol. Atherosclerosis 154 (2001) 547-555
43. Kervinen K., Södervik H., Mäkelä J., Lehtola J., Niemi M., Kairaluoma M.I., et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype?. Gastroenterology 110 (1996) 1785-1790
44. Shinomiya S., Sasaki J., Kiyohara C., Tsuji E., Inoue H., Marugame T., et al. Apolipoprotein E genotype, serum lipids, and colorectal adenomas in Japanese men. Cancer Lett 164 (2001) 33-40
45. Watson M.A., Gay L., Stebbings W.S., Speakman C.T., Bingham S.A., and Loktionov A. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis. Clin Sci 104 (2003) 537-545
46. Slattery M.L., Sweeney C., Murtaugh M., Ma K.N., Potter J.D., Levin T.R., et al. Associations between apoE genotype and colon and rectal cancer. Carcinogenesis 26 (2005) 1422-1429
47. Lei H.H., Coresh J., Shuldiner A.R., Boerwinkle E., and Brancati F.L. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African Americans. The Atherosclerosis Risk Community Study. Diabetes 48 (1999) 1868-1872
48. Pablos-Mèndez A., Mayeux R., Nagi C., Shea S., and Berglund L. Association of APO E polymorphism with plasma lipid levels in a multicentric elderly population. Arterioscler Thromb Vasc Biol 17 (1997) 3534-3541
49. Masson L.F., Sharp L., Cotton S.C., and Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 161 (2005) 901-915
50. Kamangar F., Cheng C., Abnet C.C., and Rabkin C.S. Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 1920-1928
51. Raimondi S., Paracchini V., Autrup H., Barros-Dios J.M., Benhamou S., Boffetta P., et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 164 (2006) 1027-1042
52. Cote M.L., Chen W., Smith D.W., Benhamou S., Bouchardy C., Butkiewicz D., et al. Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol 169 (2009) 802-814
53. Kruit J.K., Groen A.K., van Berkel T.J., and Kuipers F. Emerging roles of the intestine in control of cholesterol metabolism. World J Gastroenterol 12 (2006) 6429-6439
54. Williams K.J. Molecular processes that handle - and mishandle - dietary lipids. J Clin Invest 118 (2008) 3247-3259
55. Storch J., and Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu Rev Nutr 28 (2008) 73-95
56. Mansbach II C.M., and Gorelick D. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Am J Physiol Gastrointest Liver Physiol 293 (2007) G645-G650
57. van der Velde A.E., Vrins C.L., van den Oever K., Kunne C., Oude Elferink R.P., Kuipers F., et al. Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology 133 (2007) 967-975
58. Sackett D.L. Bias in analytic research. J Chron Dis 32 (1979) 51-63
59. Morimoto L.M., White E., and Newcomb P.A. Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 158 (2003) 259-263
60. Teschke K., Smith J.C., and Olshan A.F. Evidence of recall bias in volunteered vs. prompted responses about occupational exposures. Am J Ind Med 38 (2000) 385-388
61. Le Marchand L., and Wilkens L.R. Design considerations for genomic association studies: importance of gene-environment interactions. Cancer Epidemiol Biomarkers Perv 17 (2008) 263-267
62. Glatz J.F., van Nieuwenhoven F.A., Luiken J.J.F.P., Schaap F.G., and van der Vusse G.J. Role of membrane-associated and cytoplasmic fatty acid-binding proteins in cellular fatty acid metabolism. Prostagrad Leuk Essen Fat Acids 57 (1997) 373-378
63. Ogden C.L., Yanovski S.Z., Carroll M.D., and Flegal K.M. The epidemiology of obesity. Gastroenterology 132 (2007) 2087-2102